We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

COMPOUNDING CHEMOTHERAPY MARKET ANALYSIS

Compounding Chemotherapy Market, By Drug Type (Cytotoxic Drugs, Hormonal Agents, Immunomodulatory Agents, Targeted Therapies, Supportive Care Drugs), By Compounding Setting (Hospital Compounding, Compounding Pharmacies, Specialty Clinics, Homecare Settings), By Route of Administration (Intravenous (IV), Oral, Subcutaneous (SC), Intramuscular (IM), Intrathecal (IT)), By Patient Type (Adult Patients, Pediatric Patients, Geriatric Patients), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Leukemia, Lymphoma, Other specific cancer types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Compounding Method (Aseptic Compounding, Non-aseptic Compounding), By Packaging Type (Vials, Ampoules, Pre-filled Syringes, Bottles), By Regulatory Compliance (USP Chapter <797> Compliance, FDA Regulations, EMA Regulations), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Nov 2023
  • Code : CMI5892
  • Pages :200
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Regional Analysis

Compounding Chemotherapy Market Regional Insights
  • North America is the leading market for compounding chemotherapy, accounting for a share of 45.80% in 2022. The high prevalence of cancer, rising demand for personalized cancer care, and growing preference for compounded chemotherapy over commercial chemotherapy are the key factors driving the growth of the market in this region.
  • Europe is the second-largest market for compounding chemotherapy, accounting for a share of 29.20% in 2022. The rising adoption of advanced technologies in compounding pharmacies and the growing demand for compounded drugs in the region are the key factors driving the growth of the market in this region.
  • Asia Pacific is the third-largest market for compounding chemotherapy, accounting for a share of 15.00% in 2022. The increasing prevalence of cancer, rising demand for personalized cancer care, and growing preference for compounded chemotherapy over commercial chemotherapy are the key factors driving the growth of the market in this region.
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East:  GCC Countries, Israel,  Rest of Middle East
  • Africa:  South Africa, North Africa, and Central Africa 

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.